BlackRock’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.4B | Buy |
12,317,194
+223,171
| +2% | +$46.3M | 0.04% | 395 |
|
|
2026
Q1 | $2.71B | Sell |
12,094,023
-254,629
| -2% | -$63.5M | 0.05% | 327 |
|
|
2025
Q4 | $2.97B | Buy |
12,348,652
+70,686
| +0.6% | +$18.1M | 0.05% | 297 |
|
|
2025
Q3 | $3.36B | Sell |
12,277,966
-162,268
| -1% | -$44.3M | 0.06% | 274 |
|
|
2025
Q2 | $3.21B | Sell |
12,440,234
-251,780
| -2% | -$60.1M | 0.06% | 275 |
|
|
2025
Q1 | $2.84B | Buy |
12,692,014
+80,481
| +0.6% | +$18.8M | 0.06% | 285 |
|
|
2024
Q4 | $2.88B | Buy |
12,611,533
+696,843
| +6% | +$168M | 0.06% | 291 |
|
|
2024
Q3 | $2.91B | Buy |
11,914,690
+222,729
| +2% | +$49.8M | 0.06% | 282 |
|
|
2024
Q2 | $2.24B | Sell |
11,691,961
-502,574
| -4% | -$102M | 0.05% | 330 |
|
|
2024
Q1 | $2.41B | Sell |
12,194,535
-53,645
| -0.4% | -$9.83M | 0.06% | 313 |
|
|
2023
Q4 | $2.11B | Buy |
12,248,180
+148,581
| +1% | +$22.8M | 0.05% | 322 |
|
|
2023
Q3 | $1.79B | Sell |
12,099,599
-136,993
| -1% | -$24.8M | 0.05% | 336 |
|
|
2023
Q2 | $2.67B | Sell |
12,236,592
-900,870
| -7% | -$201M | 0.07% | 266 |
|
|
2023
Q1 | $2.88B | Sell |
13,137,462
-52,117
| -0.4% | -$11.3M | 0.08% | 227 |
|
|
2022
Q4 | $2.75B | Sell |
13,189,579
-164,148
| -1% | -$36.1M | 0.09% | 234 |
|
|
2022
Q3 | $2.92B | Buy |
13,353,727
+16,602
| +0.1% | +$3.78M | 0.1% | 190 |
|
|
2022
Q2 | $2.8B | Sell |
13,337,125
-22,590
| -0.2% | -$4.81M | 0.09% | 212 |
|
|
2022
Q1 | $3.24B | Buy |
13,359,715
+310,980
| +2% | +$75.2M | 0.09% | 214 |
|
|
2021
Q4 | $3.4B | Buy |
13,048,735
+360,161
| +3% | +$93.5M | 0.09% | 213 |
|
|
2021
Q3 | $3.34B | Buy |
12,688,574
+28,718
| +0.2% | +$7.85M | 0.09% | 189 |
|
|
2021
Q2 | $3.12B | Sell |
12,659,856
-750,918
| -6% | -$158M | 0.09% | 209 |
|
|
2021
Q1 | $2.6B | Sell |
13,410,774
-110,754
| -0.8% | -$22.2M | 0.08% | 246 |
|
|
2020
Q4 | $2.87B | Buy |
13,521,528
+240,047
| +2% | +$47.9M | 0.09% | 196 |
|
|
2020
Q3 | $2.28B | Buy |
13,281,481
+77,643
| +0.6% | +$14.3M | 0.08% | 212 |
|
|
2020
Q2 | $2.54B | Buy |
13,203,838
+859,377
| +7% | +$141M | 0.1% | 172 |
|
|
2020
Q1 | $1.82B | Buy |
12,344,461
+316,327
| +3% | +$50.4M | 0.09% | 201 |
|
|
2019
Q4 | $1.86B | Sell |
12,028,134
-43,994
| -0.4% | -$6.34M | 0.07% | 260 |
|
|
2019
Q3 | $1.63B | Buy |
12,072,128
+362,937
| +3% | +$47.6M | 0.07% | 271 |
|
|
2019
Q2 | $1.43B | Sell |
11,709,191
-271,225
| -2% | -$30M | 0.06% | 305 |
|
|
2019
Q1 | $1.25B | Buy |
11,980,416
+216,173
| +2% | +$22.3M | 0.06% | 334 |
|
|
2018
Q4 | $1.34B | Buy |
11,764,243
+583,831
| +5% | +$62.6M | 0.07% | 271 |
|
|
2018
Q3 | $1.29B | Buy |
11,180,412
+226,612
| +2% | +$24.8M | 0.06% | 335 |
|
|
2018
Q2 | $1.13B | Sell |
10,953,800
-233,625
| -2% | -$23.6M | 0.05% | 365 |
|
|
2018
Q1 | $1.1B | Buy |
11,187,425
+43,363
| +0.4% | +$4.1M | 0.05% | 361 |
|
|
2017
Q4 | $944M | Buy |
11,144,062
+23,017
| +0.2% | +$1.9M | 0.04% | 425 |
|
|
2017
Q3 | $856M | Sell |
11,121,045
-3,119,032
| -22% | -$239M | 0.04% | 431 |
|
|
2017
Q2 | $1.11B | Buy |
14,240,077
+904,939
| +7% | +$64.7M | 0.06% | 335 |
|
|
2017
Q1 | $960M | Buy |
13,335,138
+13,094,421
| +5,440% | +$905M | 0.05% | 367 |
|
|
2016
Q4 | $14.9M | Buy |
240,717
+20,809
| +9% | +$1.27M | 0.02% | 631 |
|
|
2016
Q3 | $14.2M | Buy |
219,908
+5,191
| +2% | +$346K | 0.02% | 634 |
|
|
2016
Q2 | $13.6M | Buy |
214,717
+26,510
| +14% | +$1.56M | 0.02% | 627 |
|
|
2016
Q1 | $10.9M | Buy |
188,207
+36,971
| +24% | +$2.09M | 0.02% | 660 |
|
|
2015
Q4 | $8.12M | Buy |
151,236
+42,404
| +39% | +$2.39M | 0.01% | 730 |
|
|
2015
Q3 | $5.55M | Buy |
108,832
+4,560
| +4% | +$245K | 0.01% | 755 |
|
|
2015
Q2 | $5.88M | Sell |
104,272
-21,489
| -17% | -$1.36M | 0.01% | 797 |
|
|
2015
Q1 | $9.03M | Sell |
125,761
-14,794
| -11% | -$961K | 0.01% | 703 |
|
|
2014
Q4 | $7.88M | Buy |
140,555
+70,273
| +100% | +$3.67M | 0.01% | 732 |
|
|
2014
Q3 | $3.46M | Sell |
70,282
-2,489
| -3% | -$127K | 0.01% | 930 |
|
|
2014
Q2 | $3.68M | Sell |
72,771
-1,834
| -2% | -$90.9K | 0.01% | 909 |
|
|
2014
Q1 | $3.33M | Sell |
74,605
-2,413
| -3% | -$108K | 0.01% | 930 |
|
|
2013
Q4 | $3.63M | Buy |
77,018
+2,947
| +4% | +$149K | 0.01% | 902 |
|
|
2013
Q3 | $3.91M | Buy |
74,071
+2,589
| +4% | +$126K | 0.01% | 821 |
|
|
2013
Q2 | $3.23M | Buy |
+71,482
| New | +$3.39M | 0.01% | 832 |
|
Other funds holding RMD
VCM
VPM
BlackRock's RMD Position: Q2 2026 in Review
BlackRock increased its ResMed (RMD) stake by 1.8% in Q2 2026, buying an estimated $46.3M and bringing the position to 12,317,194 shares worth $2.4B. The position accounts for 0.04% of the portfolio, ranked #395.
BlackRock first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.4B in Q4 2021. 698 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- BlackRock held 12,317,194 shares of ResMed worth $2.4B as of Q2 2026.
- BlackRock bought 223,171 ResMed shares in Q2 2026, an estimated $46.3M.
- ResMed made up 0.04% of BlackRock's portfolio in Q2 2026, its #395 holding.
- BlackRock first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
- BlackRock's ResMed position peaked at $3.4B in Q4 2021.
- 698 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.